REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 25 filers reported holding REDHILL BIOPHARMA LTD in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,631,000 | -73.6% | 251,509 | -64.9% | 0.29% | -67.3% |
| Q3 2016 | $9,962,000 | +24.4% | 717,203 | -2.7% | 0.89% | +14.6% |
| Q2 2016 | $8,009,000 | -20.1% | 737,156 | -9.9% | 0.78% | -19.5% |
| Q1 2016 | $10,024,000 | -6.2% | 818,265 | -1.4% | 0.97% | +47.3% |
| Q4 2015 | $10,689,000 | -0.2% | 829,906 | 0.0% | 0.66% | +10.2% |
| Q3 2015 | $10,714,000 | +58.3% | 829,906 | +116.0% | 0.60% | +63.7% |
| Q2 2015 | $6,767,000 | -4.0% | 384,281 | -20.6% | 0.36% | -33.7% |
| Q1 2015 | $7,046,000 | +5.1% | 484,281 | -3.7% | 0.55% | +88.0% |
| Q4 2014 | $6,706,000 | +93.5% | 503,018 | +91.1% | 0.29% | -19.6% |
| Q3 2014 | $3,466,000 | -62.4% | 263,160 | -50.0% | 0.36% | -19.9% |
| Q2 2014 | $9,206,000 | +148.3% | 526,320 | +100.0% | 0.45% | +26.2% |
| Q1 2014 | $3,708,000 | – | 263,160 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 444,301 | $2,284,000 | 1.33% |
| 683 Capital Management, LLC | 999,232 | $5,136,000 | 0.43% |
| DAFNA Capital Management LLC | 35,000 | $180,000 | 0.10% |
| MENORA MIVTACHIM HOLDINGS LTD. | 421,000 | $2,164,000 | 0.08% |
| Migdal Insurance & Financial Holdings Ltd. | 397,324 | $2,042,000 | 0.05% |
| Claret Asset Management Corp | 42,522 | $219,000 | 0.05% |
| Orbimed Advisors | 564,900 | $2,904,000 | 0.04% |
| Altshuler Shaham Ltd | 169,446 | $251,000 | 0.04% |
| Virtu Financial LLC | 60,787 | $312,000 | 0.02% |
| MEITAV INVESTMENT HOUSE LTD | 48,000 | $244,000 | 0.01% |